Challenges in managing patients on anticoagulation: Thrombocytopenia, resumption after bleeding and recurrent

Dawn Swan1, Jecko Thachil2

  • 1Department of Haematology, St James Hospital, Dublin, Ireland.

Insights

Anticoagulation management is complex, especially for patients with thrombosis, bleeding history, or recurrent clots. This review offers practical guidance for clinicians navigating these common challenges in anticoagulation therapy.

Area of Science:

  • Cardiology
  • Hematology
  • Internal Medicine

Background:

  • Anticoagulation prescribing is increasing globally due to aging populations and improved cancer survival.
  • Cardiovascular comorbidities like arrhythmias and prosthetic heart valves necessitate anticoagulation.
  • Managing complex anticoagulation scenarios presents significant clinical challenges.

Purpose of the Study:

  • To review common challenges in anticoagulation management.
  • To provide practical management suggestions for clinicians.
  • To discuss evidence and recommendations for complex anticoagulation cases.

Main Methods:

  • Review of current literature and published recommendations.
  • Discussion of clinical dilemmas in anticoagulation.
  • Synthesis of evidence for practical management strategies.

Main Results:

  • Identified three key challenges: thrombosis with thrombocytopenia, anticoagulation resumption post-hemorrhage, and recurrent thrombosis on therapy.
  • Considered available evidence and clinical guidelines.
  • Proposed practical management approaches for each dilemma.

Conclusions:

  • Clinicians face significant challenges in managing anticoagulation therapy.
  • Practical guidance is needed for complex cases involving thrombosis, hemorrhage, and recurrence.
  • Evidence-based recommendations can aid in optimizing patient care and safety.

Related Concept Videos

Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
19
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
18
Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
1.1K
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.3K
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
849
Pulmonary Embolism III: Nursing Management01:27

Pulmonary Embolism III: Nursing Management

A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
27